President, American University; Former U.S. Secretary of Health and Human Services under President Barack Obama (2014–2017); Co-Chair, CFR Independent Task Force on Preparing for the Next Pandemic; Member, Board of Directors, Council on Foreign Relations
President, Global Vaccine Business, Takeda Pharmaceuticals; Board Member, Coalition for Epidemic Preparedness Innovations (CEPI); Member, CFR Independent Task Force on Preparing for the Next Pandemic; Former Special Assistant to the President for Biodefense (2005-2007); CFR Member
President and Executive Director, Foundation for the National Institutes of Health
Panelists discuss the challenges of ending the COVID-19 pandemic and what steps the Biden administration should take to curb the spread, including increased and improved testing and an equitable and efficient vaccine distribution.
The Transition 2021 series examines the major issues confronting the administration in the foreign policy arena.